Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Boston Scientific Receives FDA OK for New Balloon Catheter; Begins Stent Trial - Medical Product Outsourcing

Boston Scientific Receives FDA OK for New Balloon Catheter; Begins Stent Trial

New balloon catheter launched in the U.S.; stent trial begins in Europe

Boston Scientific received U.S. Food and Drug Administration (FDA) clearance to market a new balloon-style catheter in the United States and European Union.

The Natick, Mass.-based firm said its NC Quantum Apex PTCA Dilation Balloon Catheter is intended for use in coronary angioplasty and stent procedures, which are designed to open arteries that have been blocked by atherosclerosis. The condition can cause strokes or heart attacks.

Boston Scientific officials said the device is available with a variety of balloon diameters and lengths. The company plans to launch the catheter in Europe this week and in the United States in June.

In other product development news, the company has begun a clinical trial for its Promus Element Stent. The stent was approved in Europe with a CE Mark in October and is designed to have more radial strength and flexibility as part of its platinum chromium alloy architecture, according to the company.

The trial, called the Platinum Plus clinical trial, will enroll 3,000 patients through 50 sites located in France, Spain, Germany, Italy and the United Kingdom. Patients will participate in the random trial, receiving either the Promus Element Stent or the Xience Prime Stent. The trial will support Boston Scientific’s efforts for regulatory approval by the U.S. Food and Drug Administration and the Japanese Ministry of Health.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters